Market Tracker

05/22 5:16pm ET

GlaxoSmithKline PLC (NYSE:GSK)

43.30
Delayed Data
As of 4:02pm ET
 -0.30 / -0.69%
Today’s Change
37.20
Today|||52-Week Range
45.58
+12.44%
Year-to-Date
Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion
6:32pm / Zacks.com - Paid Partner Content
Ionis (IONS) Stock Falls Despite Positive Inotersen Data
May 16 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications
May 19 / Zacks.com - Paid Partner Content
GlaxoSmithKline Could Buy Out Partner Novartis
May 15 / TheStreet.com - Paid Partner Content
Hikma Trims Full Year Revenue Guidance After Advair Diskus Delay
May 19 / TheStreet.com - Paid Partner Content
Mylan (MYL) Beats on Q1 Earnings, Revenues Miss Estimates
May 10 / Zacks.com - Paid Partner Content
Huge Downgrades Loom Over Hikma Pharmaceuticals
May 17 / TheStreet.com - Paid Partner Content
Epizyme (EPZM) Incurs Narrower-than-Expected Loss in Q1
May 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close43.60
Today’s open43.44
Day’s range43.23 - 43.60
Volume3,394,320
Average volume (3 months)3,207,559
Market cap$107.2B
Dividend yield4.60%
Data as of 4:02pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+12.45%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+2.85%
P/E ratio63.5
Price/Sales2.52
Price/Book76.40

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.14-0.21%
CELGCelgene-1.22-1.04%
BMYBristol-Myers Squibb+0.08+0.15%
LLYEli Lilly and Co-0.82-1.05%
Data as of 4:14pm ET, 05/22/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)$0.69
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts